Radcliffe Capital Management’s EUDA Health Holdings Warrant EUDAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,345
Closed -$124K 889
2022
Q3
$124K Sell
12,345
-37,655
-75% -$12.2K ﹤0.01% 1169
2022
Q2
$494K Buy
+50,000
New +$14.2K 0.01% 1128

Other funds holding EUDAW

Radcliffe Capital Management's EUDAW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of EUDA Health Holdings Warrant (EUDAW) in Q4 2022, closing a stake of 12,345 shares — an estimated $124K sold.

Radcliffe Capital Management first reported a position in EUDAW in Q2 2022 and held it in 2 quarters. The position peaked at $494K in Q2 2022. 13 funds tracked by Wall St. Rank hold EUDAW as of Q4 2022.

  • Radcliffe Capital Management reported no remaining EUDA Health Holdings Warrant position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 12,345 EUDA Health Holdings Warrant shares in Q4 2022, an estimated $124K.
  • Radcliffe Capital Management first reported a position in EUDA Health Holdings Warrant in Q2 2022 and held it in 2 quarters.
  • Radcliffe Capital Management's EUDA Health Holdings Warrant position peaked at $494K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held EUDA Health Holdings Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.